Professor Neil Hanley

Professor Neil Hanley

Medical and Dental Sciences
Pro-Vice-Chancellor and Head of the College of Medical and Dental Sciences

Contact details

University of Birmingham
B15 2TT

Professor Neil Hanley became Pro-Vice-Chancellor and Head of the College of Medical and Dental Sciences in September 2023. Neil previously was Vice-Dean (Research and Innovation) in the Faculty of Biology, Medicine and Health at the University of Manchester.

Google Scholar Profile


  • PhD in Molecular Genetics - Newcastle University
  • MRCP Royal College of Physicians; now FRCP
  • MBChB - University of Edinburgh
  • BSc in Pharmacology - University of Edinburgh


Neil joined the University of Birmingham as Pro-Vice-Chancellor and Head of the College of Medical and Dental Sciences in September 2023 and is also a practising Consultant Endocrinologist in the NHS.

Neil was first made full professor in 2006 and is a past president of the Association of Physicians of Great Britain and Ireland. Neil was at the University of Manchester from 2008-2023, becoming Director of Research and Innovation at Manchester University NHS Foundation Trust in 2016, and Vice-Dean (Research and Innovation) in the Faculty of Biology, Medicine and Health in 2020. During this time, he has also served on the Council of his UK professional body, the Society for Endocrinology, and on the Board of the International Society of Endocrinology.

An expert in early human development and aspects of stem cell biology, Neil has held doctoral, intermediate, and senior clinical fellowships from NIHR or Wellcome, and additional funding as lead investigator from MRC, BBSRC and EPSRC, among others. During the last decade, this has led to outputs in places such as eLife, PNAS, and several Nature journals with over 8,000 citations. His current partnership as chief investigator with Innovate UK and industry leaders has translated collaborative discovery science into integrated novel diagnostics for the early detection of liver disease.

He recognises the critical role of innovation in the Life Sciences and Healthcare. In Manchester, he was a key player in helping to place industries within the university and NHS setting and is now continuing this work focused on healthcare outcomes and economic growth in the West Midlands, for example through Birmingham Health Partners and the Birmingham Health Innovation Campus.

Neil has a passion for education and training, having established an academy in Manchester for those embarking on their own research careers. He directed the Wellcome-funded PhD programme for healthcare professionals for 8 years across the universities of Leeds, Manchester, Newcastle and Sheffield, led the future vision of NIHR’s 2016 national review of training, and is the incoming Chair of the Molecular, Cellular & Physiological Sciences Eary Career Advisory Group at Wellcome.

Other activities

  • Association of Physicians (President, 2018-2019)
  • Society for Endocrinology (Council 2014-2018)
  • Endocrine Society
  • Fellow of the Royal College of Physicians


Recent publications


Shapey, IM, Summers, A, O'Sullivan, J, Fullwood, C, Hanley, NA, Casey, J, Forbes, S, Rosenthal, M, Johnson, PRV, Choudhary, P, Bushnell, J, Shaw, JAM, Neiman, D, Shemer, R, Glaser, B, Dor, Y, Augustine, T, Rutter, MK & van Dellen, D 2023, 'Beta-cell death and dysfunction drives hyperglycaemia in organ donors', Diabetes, Obesity and Metabolism.

PHOSP-COVID study collaborative group, Jackson, C, Stewart, ID, Plekhanova, T, Cunningham, PS, Hazel, AL, Al-Sheklly, B, Aul, R, Bolton, CE, Chalder, T, Chalmers, JD, Chaudhuri, N, Docherty, AB, Donaldson, G, Edwardson, CL, Elneima, O, Greening, NJ, Hanley, NA, Harris, VC, Harrison, EM, Ho, L-P, Houchen-Wolloff, L, Howard, LS, Jolley, CJ, Jones, MG, Leavy, OC, Lewis, KE, Lone, NI, Marks, M, McAuley, HJC, McNarry, MA, Patel, BV, Piper-Hanley, K, Poinasamy, K, Raman, B, Richardson, M, Rivera-Ortega, P, Rowland-Jones, SL, Rowlands, AV, Saunders, RM, Scott, JT, Sereno, M, Shah, AM, Shikotra, A, Singapuri, A, Stanel, SC, Thorpe, M, Wootton, DG, Yates, T, Gisli Jenkins, R, Singh, SJ, Man, WD-C, Brightling, CE, Wain, LV, Porter, JC, Thompson, AAR, Horsley, A, Molyneaux, PL, Evans, RA, Jones, SE, Rutter, MK, Blaikley, JF & Sapey, E 2023, 'Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study', The Lancet Respiratory Medicine, vol. 11, no. 8, pp. 673-684.

Wong, YF, Kumar, Y, Proks, M, Herrera, JAR, Rothová, MM, Monteiro, RS, Pozzi, S, Jennings, RE, Hanley, NA, Bickmore, WA & Brickman, JM 2023, 'Expansion of ventral foregut is linked to changes in the enhancer landscape for organ-specific differentiation', Nature Cell Biology, vol. 25, no. 3, pp. 481-492.

PHOSP-COVID study collaborative group 2023, 'Residual Lung Abnormalities after COVID-19 Hospitalization Interim Analysis of the UKILD Post-COVID-19 Study', American Journal of Respiratory and Critical Care Medicine, vol. 207, no. 6, pp. 693-703.

ISARIC4C Investigators, PHOSP-COVID Collaborative Group, Liew, F, Talwar, S, Cross, A, Willett, BJ, Scott, S, Logan, N, Siggins, MK, Swieboda, D, Sidhu, JK, Efstathiou, C, Moore, SC, Davis, C, Mohamed, N, Nunag, J, King, C, Thompson, AAR, Rowland-jones, SL, Docherty, AB, Chalmers, JD, Ho, L-P, Horsley, A, Raman, B, Poinasamy, K, Marks, M, Kon, OM, Howard, L, Wootton, DG, Dunachie, S, Quint, JK, Evans, RA, Wain, LV, Fontanella, S, De Silva, TI, Ho, A, Harrison, E, Baillie, JK, Semple, MG, Brightling, C, Thwaites, RS, Turtle, L, Openshaw, PJM, Kamwa, V & Hanley, N 2023, 'SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination', EBioMedicine, vol. 87, 104402.

Purssell, H, Bennett, L, Street, O, Hanley, KP, Hanley, N, Vasant, DH & Athwal, VS 2023, 'The prevalence and burden of Rome IV bowel disorders of gut brain interaction in patients with non-alcoholic fatty liver disease: a cross-sectional study', Scientific Reports, vol. 13, no. 1, 8769.

PHOSP-COVID Collaborative Group, Kamwa, V, Yip, KP & Hanley, N 2022, 'Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study', The Lancet Respiratory Medicine, vol. 10, no. 8, pp. 761-775.

the ID-LIVER Consortium 2022, 'Health Technology Adoption in Liver Disease: Innovative Use of Data Science Solutions for Early Disease Detection', Frontiers in digital health, vol. 4, 737729.

van der Zanden, LFM, van Rooij, IALM, Quaedackers, JSLT, Nijman, RJM, Steffens, M, de Wall, LLL, Bongers, EMHF, Schaefer, F, Kirchner, M, Behnisch, R, Bayazit, AK, Caliskan, S, Obrycki, L, Montini, G, Duzova, A, Wuttke, M, Jennings, R, Hanley, NA, Milmoe, NJ, Winyard, PJD, Renkema, KY, Schreuder, MF, Roeleveld, N & Feitz, WFJ 2021, 'CDH12 as a Candidate Gene for Kidney Injury in Posterior Urethral Valve Cases: A Genome-wide Association Study Among Patients with Obstructive Uropathies', European Urology Open Science, vol. 28, pp. 26-35.

Shapey, IM, Summers, A, Khambalia, H, Yiannoullou, P, Fullwood, C, Hanley, NA, Augustine, T, Rutter, MK & van Dellen, D 2021, 'Donor insulin therapy in intensive care predicts early outcomes after pancreas transplantation', Diabetologia, vol. 64, no. 6, pp. 1375-1384.

Vekaria, B, Overton, C, Wiśniowski, A, Ahmad, S, Aparicio-Castro, A, Curran-Sebastian, J, Eddleston, J, Hanley, NA, House, T, Kim, J, Olsen, W, Pampaka, M, Pellis, L, Ruiz, DP, Schofield, J, Shryane, N & Elliot, MJ 2021, 'Hospital length of stay for COVID-19 patients: Data-driven methods for forward planning', BMC Infectious Diseases, vol. 21, no. 1, 700.

Shapey, IM, Tan, ZL, Gioco, R, Khambalia, H, Fullwood, C, Yiannoullou, P, Summers, A, Hanley, NA, Augustine, T, Rutter, MK & van Dellen, D 2021, 'Peri-transplant glycaemic control as a predictor of pancreas transplant survival', Diabetes, Obesity and Metabolism, vol. 23, no. 1, pp. 49-57.

PHOSP-COVID Collaborative Group, Lord, J, Parekh, D, Kamwa, V, Yip, A & Hanley, N 2021, 'Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study', The Lancet Respiratory Medicine, vol. 9, no. 11, pp. 1275-1287.

Raza, S, Jokl, E, Pritchett, J, Martin, K, Su, K, Simpson, K, Birchall, L, Mullan, AF, Athwal, VS, Doherty, DT, Zeef, L, Henderson, NC, Kalra, PA, Hanley, NA & Hanley, KP 2021, 'SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function', Science signaling, vol. 14, no. 672, eabb4282.


Shapey, IM, Summers, A, Khambalia, H, Yiannoullou, P, Fullwood, C, Hanley, NA, Augustine, T, Rutter, MK & van Dellen, D 2021, 'Donor insulin use during stay in the intensive care unit should not preclude pancreas transplantation. Reply to Ventura-Aguiar P, Montagud-Marrahi E, Amor AJ et al [letter]', Diabetologia, vol. 64, no. 9, pp. 2124-2125.

View all publications in research portal